Survivin as prognostic factor in squamous cell carcinoma of the oral cavity

被引:49
作者
Lo Muzio, L
Farina, A
Rubini, C
Pezzetti, F
Stabellini, G
Laino, G
Santarelli, A
Pannone, G
Bufo, P
de Lillo, A
Carinci, F
机构
[1] Univ Foggia, Dept Surg, I-71100 Foggia, Italy
[2] Univ Bologna, Inst Histol, Bologna, Italy
[3] Univ Ancona, Inst Pathol, Ancona, Italy
[4] Univ Milan, Inst Anat, Milan, Italy
[5] Univ Naples 2, Dept Maxillofacial Surg, Naples, Italy
[6] Univ Ferrara, Inst Maxillofacial Surg, I-44100 Ferrara, Italy
关键词
oral squamous cell carcinoma; cancer; survival; survivin; Cox analysis;
D O I
10.1016/j.canlet.2004.11.024
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A series of 78 cases of oral squamous cell carcinoma was analysed by immunohistochemistry for expression of survivin, a recent apoptosis inhibitor. All cases were positive for survivin expression and were divided into two groups using a system of scores. Disease-specific survival curves were calculated according to Kaplan-Meier algorithm, and log rank test was used to compare survival curves. Then, Cox regression analysis was applied to determine the single contribution of covariates on survival rate. So, Cox analysis allowed us to detect the variables most associated to survival. Among the studied variables, such as grade of differentiation, tumor size, stage, recurrence of disease, lymph node presence, only stage and recurrence of disease were predictors of outcome; however, when we analyzed the survival without considering recurrence (that was the stronger predictor of death), a stepwise Cox analysis showed that Survivin, stage and grade of differentiation are significantly associated to survival, with a higher value for Survivin. These data suggest that survivin expression may identify cases of oral squamous cell carcinoma with more aggressive and invasive phenotype and, therefore, could influence the decision for the therapy at the time of diagnosis. (c) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:27 / 33
页数:7
相关论文
共 36 条
[1]   Anti-apoptosis gene, survivin, and prognosis of neuroblastoma [J].
Adida, C ;
Berrebi, D ;
Peuchmaur, M ;
Reyes-Mugica, M ;
Altieri, DC .
LANCET, 1998, 351 (9106) :882-883
[2]  
Adida C, 1998, AM J PATHOL, V152, P43
[3]   Validating survivin as a cancer therapeutic target [J].
Altieri, DC .
NATURE REVIEWS CANCER, 2003, 3 (01) :46-54
[4]   A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma [J].
Ambrosini, G ;
Adida, C ;
Altieri, DC .
NATURE MEDICINE, 1997, 3 (08) :917-921
[5]   Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting [J].
Ambrosini, G ;
Adida, C ;
Sirugo, G ;
Altieri, DC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (18) :11177-11182
[6]  
CHAWLASARKAR M, 2004, CELL DEATH DIFFER
[7]   Expression of the novel inhibitor of apoptosis survivin in normal and neoplastic skin [J].
Chiodino, C ;
Cesinaro, AM ;
Ottani, D ;
Fantini, F ;
Giannetti, A ;
Trentini, GP ;
Pincelli, C .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 113 (03) :415-418
[8]   AN APOPTOSIS-INHIBITING BACULOVIRUS GENE WITH A ZINC FINGER-LIKE MOTIF [J].
CROOK, NE ;
CLEM, RJ ;
MILLER, LK .
JOURNAL OF VIROLOGY, 1993, 67 (04) :2168-2174
[9]  
Dawson-Saunders B., 1994, Basic and clinical biostatistics, V2
[10]   X-linked IAP is a direct inhibitor of cell-death proteases [J].
Deveraux, QL ;
Takahashi, R ;
Salvesen, GS ;
Reed, JC .
NATURE, 1997, 388 (6639) :300-304